BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2553435)

  • 1. Magnitude of opioid dependence after continuous intrathecal infusion of mu- and delta-selective opioids in the rat.
    Stevens CW; Yaksh TL
    Eur J Pharmacol; 1989 Aug; 166(3):467-72. PubMed ID: 2553435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):1-8. PubMed ID: 2526212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A; Petrillo P; La Regina A; Sbacchi M
    J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
    Dray A; Metsch R
    Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
    Mjanger E; Yaksh TL
    J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M; La Regina A; Petrillo P; Tavani A
    NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats.
    Pazos A; Flórez J
    Eur J Pharmacol; 1983 Feb; 87(2-3):309-14. PubMed ID: 6301857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
    Kiritsy-Roy JA; Marson L; Van Loon GR
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternated delta and mu receptor activation: a stratagem for limiting opioid tolerance.
    Russell RD; Kwen-Jen C
    Pain; 1989 Mar; 36(3):381-389. PubMed ID: 2540475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.
    Abdelhamid EE; Takemori AE
    Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique.
    Jensen TS; Yaksh TL
    Brain Res; 1986 May; 372(2):301-12. PubMed ID: 2871901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine and enkephalins potently inhibit [3H]noradrenaline release from rat brain cortex synaptosomes: further evidence for a presynaptic localization of mu-opioid receptors.
    Mulder AH; Hogenboom F; Wardeh G; Schoffelmeer AN
    J Neurochem; 1987 Apr; 48(4):1043-7. PubMed ID: 3029324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central opioid modulation of fetal cardiovascular function: role of mu- and delta-receptors.
    Szeto HH; Zhu YS; Cai LQ
    Am J Physiol; 1990 Jun; 258(6 Pt 2):R1453-8. PubMed ID: 2163223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.